BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8482811)

  • 1. Uptake of serotonin into platelets of senile dementia of the Alzheimer type patients.
    Koren P; Diver-Haber A; Adunsky A; Rabinowitz M; Hershkowitz M
    J Gerontol; 1993 May; 48(3):B93-6. PubMed ID: 8482811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake of 5-hydroxytryptamine by blood platelets in Huntington's chorea and Alzheimer type of presenile dementia.
    Tukiainen E; Wikström J; Kilpeläinen H
    Med Biol; 1981 Apr; 59(2):116-20. PubMed ID: 6458746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type.
    Chalmers DT; Dewar D; Graham DI; Brooks DN; McCulloch J
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1352-6. PubMed ID: 2154742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet 3H-imipramine binding distinguishes depression from Alzheimer dementia.
    Suranyi-Cadotte BE; Gauthier S; Lafaille F; DeFlores S; Dam TV; Nair NP; Quirion R
    Life Sci; 1985 Dec; 37(24):2305-11. PubMed ID: 2999549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin uptake and its kinetics in platelets of women with Alzheimer's disease.
    Kumar AM; Kumar M; Sevush S; Ruiz J; Eisdorfer C
    Psychiatry Res; 1995 Nov; 59(1-2):145-50. PubMed ID: 8771229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer and platelets: low-density platelet populations reveal increased serotonin content in Alzheimer type dementia.
    Milovanovic M; Eriksson K; Winblad B; Nilsson S; Lindahl TL; Post C; Järemo P
    Clin Biochem; 2014 Oct; 47(15):51-3. PubMed ID: 25041722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in blood glucose and insulin secretion in patients with senile dementia of Alzheimer type.
    Bucht G; Adolfsson R; Lithner F; Winblad B
    Acta Med Scand; 1983; 213(5):387-92. PubMed ID: 6349261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced Vmax of 3H-serotonin uptake but unchanged 3H-imipramine binding in the platelets of untreated hypertensive subjects.
    Kamal LA; Raisman R; Meyer P; Langer SZ
    Life Sci; 1984 May; 34(21):2083-8. PubMed ID: 6328154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological studies in senile dementia of the Alzheimer type: evidence for enhanced suppressor cell activity.
    Miller AE; Neighbour PA; Katzman R; Aronson M; Lipkowitz R
    Ann Neurol; 1981 Dec; 10(6):506-10. PubMed ID: 6173011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin uptake in the blood platelets of Alzheimer's disease patients.
    Arora RC; Emery OB; Meltzer HY
    Neurology; 1991 Aug; 41(8):1307-9. PubMed ID: 1866025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin uptake in subpopulations of normal human blood platelets.
    Arora RC; Meltzer HY
    Biol Psychiatry; 1982 Oct; 17(10):1157-62. PubMed ID: 7171659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dehydroepiandrosterone sulfate decreases the interleukin-2-mediated overactivity of the natural killer cell compartment in senile dementia of the Alzheimer type.
    Solerte SB; Fioravanti M; Schifino N; Cuzzoni G; Fontana I; Vignati G; Govoni S; Ferrari E
    Dement Geriatr Cogn Disord; 1999; 10(1):21-7. PubMed ID: 9844034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet of Alzheimer patients: increased counts and subnormal uptake and accumulation of [14C]5-hydroxytryptamine.
    Inestrosa NC; Alarcón R; Arriagada J; Donoso A; Alvarez J
    Neurosci Lett; 1993 Nov; 163(1):8-10. PubMed ID: 8295739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Senile dementia, Alzheimer type: a distinct entity in the immunosenescence?
    Antonaci S; Garofalo AR; Chicco C; Polignano AV; Pugliese P; Misefari A; Jirillo E
    J Clin Lab Anal; 1990; 4(1):16-21. PubMed ID: 1968967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hair aluminium in normal aged and senile dementia of Alzheimer type.
    Kobayashi S; Fujiwara S; Arimoto S; Koide H; Fukuda J; Shimode K; Yamaguchi S; Okada K; Tsunematsu T
    Prog Clin Biol Res; 1989; 317():1095-109. PubMed ID: 2602406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine metabolism in senile dementia of Alzheimer type.
    Cross AJ; Crow TJ; Johnson JA; Joseph MH; Perry EK; Perry RH; Blessed G; Tomlinson BE
    J Neurol Sci; 1983; 60(3):383-92. PubMed ID: 6195313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Senile dementia of Alzheimer's type (SDAT): reduced T8+-cell-mediated suppressor activity.
    Skias D; Bania M; Reder AT; Luchins D; Antel JP
    Neurology; 1985 Nov; 35(11):1635-8. PubMed ID: 2932656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral serotonin in Alzheimer's disease.
    Kumar AM; Sevush S; Kumar M; Ruiz J; Eisdorfer C
    Neuropsychobiology; 1995; 32(1):9-12. PubMed ID: 7566524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of acute tryptophan depletion on cognitive function in Alzheimer's disease and in the healthy elderly.
    Porter RJ; Lunn BS; O'Brien JT
    Psychol Med; 2003 Jan; 33(1):41-9. PubMed ID: 12537035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non-demented elderly control patients.
    Ince P; Irving D; MacArthur F; Perry RH
    J Neurol Sci; 1991 Dec; 106(2):142-52. PubMed ID: 1802962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.